GH Research (GHRS) Times Interest Earned (2021 - 2025)
GH Research (GHRS) recorded quarterly Times Interest Earned of -$20.0 in Q4 2025, down 102.54% quarter-over-quarter from $788.81 in Q3 2025, and down 93.88% on a YoY basis from -$326.6 in Q4 2024.
GH Research (GHRS) Times Interest Earned (2021 - 2025) Analysis & Trends
GH Research's Times Interest Earned history runs 5 years deep, the most recent figure standing at -$20.0 for Q4 2025.
- In Q4 2025, Times Interest Earned fell 93.88% year-over-year to -$20.0; the TTM figure through Dec 2025 stood at -$131.14 (down 180.2% YoY), while the FY2025 annual figure was -$131.14, down 86.89% from the prior year.
- Times Interest Earned was -$20.0 for Q4 2025 at GH Research, down from $788.81 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1555.3 in Q3 2021 to a low of -$74.57 in Q4 2022.
- Historically, Times Interest Earned has averaged $205.38 across 5 years, with a median of $60.93 in 2023.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned tumbled 205.7% in 2024, then surged 1031.25% in 2025.
- A 5-year view of Times Interest Earned shows it stood at $1555.3 in 2021, then sank by 104.79% to -$74.57 in 2022, then jumped by 88.09% to -$8.88 in 2023, then dropped by 16.18% to -$10.31 in 2024, then slumped by 93.88% to -$20.0 in 2025.
- The last three Times Interest Earned figures came in at -$20.0 (Q4 2025), $788.81 (Q3 2025), and $84.51 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | -20.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.00 |
| Sep 30, 2025 | 788.81 |
| Jun 30, 2025 | 84.51 |
| Mar 31, 2025 | 71.53 |
| Dec 31, 2024 | -10.31 |
| Sep 30, 2024 | 69.73 |
| Jun 30, 2024 | 74.26 |
| Mar 31, 2024 | -64.40 |
| Dec 31, 2023 | -8.88 |
| Sep 30, 2023 | 52.82 |
| Jun 30, 2023 | 55.45 |
| Mar 31, 2023 | 60.93 |
| Dec 31, 2022 | -74.57 |
| Sep 30, 2021 | 1,555.33 |
| Jun 30, 2021 | 445.50 |